Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 1156 AL 1170

Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

Veitch DP, Weiner MW, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR Jr, Jagust W, Morris JC, Petersen RC, Saykin AJ, Shaw LM, Toga AW, Trojanowski JQ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2019 Jan;15(1):106-152. doi: 10.1016/j.jalz.2018.08.005. Epub 2018 Oct 13.

In vivo molecular imaging of neuroinflammation in Alzheimer's disease

Chaney A, Williams SR, Boutin H.

J Neurochem. 2019 May;149(4):438-451. doi: 10.1111/jnc.14615. Epub 2018 Nov 26.

Blood-based biomarkers for Alzheimer's disease-An update

Zetterberg H.

J Neurosci Methods. 2019 May 1;319:2-6. doi: 10.1016/j.jneumeth.2018.10.025. Epub 2018 Oct 25.

Every Three Seconds: A Review of an Innovative Documentary on Research and Stigma Surrounding Dementia Across the Globe

Hand MD.

J Gerontol Soc Work. 2019 Apr;62(3):369-373. doi: 10.1080/01634372.2018.1541951. Epub 2018 Oct 30.

Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature

Marshe VS, Gorbovskaya I, Kanji S, Kish M, Müller DJ.

J Neural Transm (Vienna). 2019 Jan;126(1):65-85. doi: 10.1007/s00702-018-1934-9. Epub 2018 Oct 31.

microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer

Nagaraj S, Zoltowska KM, Laskowska-Kaszub K, Wojda U.

Ageing Res Rev. 2019 Jan;49:125-143. doi: 10.1016/j.arr.2018.10.008. Epub 2018 Nov 2.

Relating constructs of attention and working memory to social withdrawal in Alzheimer's disease and schizophrenia: issues regarding paradigm selection

Gilmour G, Porcelli S, Bertaina-Anglade V, Arce E, Dukart J, Hayen A, Lobo A, Lopez-Anton R, Merlo Pich E, Pemberton DJ, Havenith MN, Glennon JC, Harel BT, Dawson G, Marston H, Kozak R, Serretti A.

Neurosci Biobehav Rev. 2019 Feb;97:47-69. doi: 10.1016/j.neubiorev.2018.09.025. Epub 2018 Nov 3.

Amyloid beta soluble forms and plasminogen activation system in Alzheimer's disease: Consequences on extracellular maturation of brain-derived neurotrophic factor and therapeutic implications

Angelucci F, Čechová K, Průša R, Hort J.

CNS Neurosci Ther. 2019 Mar;25(3):303-313. doi: 10.1111/cns.13082. Epub 2018 Nov 6.

An elderly patient with Alzheimer's disease, normal pressure hydrocephalus and traumatic brain injury: presented with behavioral symptoms similar to behavioral variant frontotemporal dementia

Ates Bulut E, Karabay N, Soysal P, Isik AT.

Int J Neurosci. 2019 Jun;129(6):623-626. doi: 10.1080/00207454.2018.1552690. Epub 2018 Dec 21.

Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease

Cohen AD, Landau SM, Snitz BE, Klunk WE, Blennow K, Zetterberg H.

Mol Cell Neurosci. 2019 Jun;97:3-17. doi: 10.1016/j.mcn.2018.12.004. Epub 2018 Dec 8.

Genetic influences on white matter and metabolism abnormal change in Alzheimer's disease: Meta-analysis for neuroimaging research on presenilin 1 mutation

Gu X, Chu T, Liu L, Han X.

Clin Neurol Neurosurg. 2019 Feb;177:47-53. doi: 10.1016/j.clineuro.2018.12.016. Epub 2018 Dec 26.

Diet and biomarkers of Alzheimer's disease: a systematic review and meta-analysis

Hill E, Goodwill AM, Gorelik A, Szoeke C.

Neurobiol Aging. 2019 Apr;76:45-52. doi: 10.1016/j.neurobiolaging.2018.12.008. Epub 2018 Dec 27.

Usability study and pilot validation of a computer-based emotion recognition test for older adults with Alzheimer's disease and amnestic mild cognitive impairment

García-Casal JA, Martínez-Abad F, Cid-Bartolomé T, Smith SJ, Llano-Ordóñez K, Perea-Bartolomé MV, Goñi-Imizcoz M, Soto-Pérez F, Franco-Martín M.

Aging Ment Health. 2019 Mar;23(3):365-375. doi: 10.1080/13607863.2017.1423033. Epub 2018 Jan 22.

Vitamin D status and risk of dementia and Alzheimer's disease: A meta-analysis of dose-response (†)

Jayedi A, Rashidy-Pour A, Shab-Bidar S.

Nutr Neurosci. 2019 Nov;22(11):750-759. doi: 10.1080/1028415X.2018.1436639. Epub 2018 Feb 15.

Interaction between memory impairment and depressive symptoms can exacerbate anosognosia: a comparison of Alzheimer's disease with mild cognitive impairment

Oba H, Matsuoka T, Imai A, Fujimoto H, Kato Y, Shibata K, Nakamura K, Narumoto J.

Aging Ment Health. 2019 May;23(5):595-601. doi: 10.1080/13607863.2018.1442411. Epub 2018 Mar 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias